Jennifer Swieton
A5041105650- Autoimmune Bullous Skin Diseases
- Platelet Disorders and Treatments
- Lymphoma Diagnosis and Treatment
- Blood groups and transfusion
- Trauma and Emergency Care Studies
- Chronic Lymphocytic Leukemia Research
- Abdominal Trauma and Injuries
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Lung Cancer Treatments and Mutations
Newcastle upon Tyne Hospitals NHS Foundation Trust
2018-2019
Freeman Hospital
2017
SUMMARY Objectives The aim of this study is to improve practice in the management major haemorrhage, particularly red cell plasma transfusion ratios. Background A review haemorrhage trauma Newcastle Hospitals Trust 2012–2013 showed good mortality outcomes but found that : ratios could be improved. Human factors techniques transferable from industry and military were identified, a package interventions was implemented, including an intensive multidisciplinary team training programme new...
Intravenous immunoglobulin (IVIg) is a common therapy for patients with immune thrombocytopenia (ITP). The initial response rate IVIg 80%[1][1] and typically rapid, some responding in 24 hours, although usually 2–4 days.[2][2] When used alone, the
Intravenous immunoglobulin (IVIg) is a common therapy for patients with immune thrombocytopenia (ITP). The initial response rate IVIg 80%[1][1] and typically rapid, some responding in 24 hours, although usually 2–4 days.[2][2] When used alone, the
Introduction: Double hit lymphoma is a highly aggressive B-cell subtype characterised by rearrangements of the MYC and BCL2 genes. Prognosis poor, there no accepted standard care. Methods: All patients with in fluorescence situ hybridisation were identified Northern Genetics Service. Retrospective data collected on all available including demographic disease-specific variables, treatment delivered. Response to primary treatment, relapse free overall survival then estimated. Results: Between...